Phosphate-Rich Fluid for Kidney Failure Blood Cleaning
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a special fluid used during continuous kidney-cleaning treatment (CRRT) that contains phosphate. The study examines whether this formulation helps patients whose kidneys have stopped working and need ongoing blood filtration.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your doctor confirms you need continuous blood-cleaning therapy (CRRT) for kidney failure
- You need this treatment for at least 3 days or longer
- You have a suitable vein or access point for the blood-cleaning machine
- You are not pregnant, breastfeeding, or in another drug trial in the past month
- Your blood pressure is stable enough to tolerate this treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to safely remove excess fluid from patients in the ICU who have sudden kidney failure and are on a special blood-filtering machine (CRRT). Researchers want to understand which patients have trouble tolerating fluid removal and how to prevent complications.
This study looks at using a blood thinner called citrate during continuous kidney dialysis (renal replacement therapy) in critically ill patients with acute kidney injury. It aims to see if this approach is safe and workable for patients whose bodies may not process citrate normally.
This trial tests a special device that filters parts of the blood to calm inflammation in people with severe acute kidney injury in the ICU. It may help improve recovery and reduce complications by “deactivating” certain immune cells.
This trial looks at how a type of continuous kidney dialysis, called CRRT, works in very sick patients in the intensive care unit. It may help doctors learn more about how to best care for people who need this treatment.
This study tests whether a specific blood-thinning method using citrate works safely and effectively in critically ill patients whose kidneys have suddenly stopped working and need a special filtering machine. Researchers want to confirm that this approach prevents dangerous blood clots while keeping patients safe.
This trial tests if adding an iron chelator (MEX-CD1) to the dialysis fluid can help remove harmful iron from the blood in patients with sepsis-related acute kidney injury who need continuous dialysis. It may reduce damage to the kidneys and other organs.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.